ALA

3.45%

14.0¢ arovella therapeutics limited

Has Suda turned the corner!, page-33

First 33 Last

Share
Profile

Follow
Beale

3,660 Posts.

655

13/11/18

18:57

Post #: 36490019
Share

Originally posted by F18FDG ↑

Actually, now you have me after closing, my real SUD sentiment is this.

I have been watching this slow moving train wreck since Peter Jooste was in short pants. I'm honestly super excited at the potential of SUD's oral mucusal delivery technology and how, when applied to the myriad of brilliant, effective and cheap generic drugs, it could re-create/re-invigorate these massive existing markets with very little effort and make masses of money.

But I'm skeptical too - if they have a super dooper delivery tech, do other players and how does it really compare? If the tech's so good, where's the publication record in leading journals? If the reformulation and delivery is so effective at drug delivery, where's the pre-clinical, animal, tox, clinical data? For more than one indication/product?

But If I'm not right and everything's in the bag, why is it that the commercial partnerships they do already have are so long in the tooth they give Grandma Poss, Roland Rat and Jacinda Adern a run for the 'I've got the biggest teeth on the global stage' award? If all these issues I have suggested were just perception, then why are Dr Reddy or Sandoz (or Pfizer for that matter) not knocking the door down and seriously partnering?

So why the low (and declining) sp? Could it be that the technology is just not that good, or that the evidence they do have is just not that convincing? Or, if these technical issues aren't real, could it be that the company is being poorly managed?

I don't know these answers, and frankly, neither do any of the posters on this site except for the stooges and patsies (there's always a stooge in small-cap bio threads). On that basis, I cannot currently see how an investment in SUD is anything more than a Flemington flutter on Ladies Day - and I don't care for the ponies.

Expand

Your posts are actually quite good. Im hoping its poor management that is being turned around or as CBD states they have turned the corner. Im also hoping a lot more will happen prior to christmas.

SUD Price at posting: 0.7¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Microcap Wrap: 5 explorers with news out today

There are more pages in this discussion • 1 more message in this thread...

First 33 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 14.0¢		Change -0.005(3.45%)		Mkt cap ! $147.0M

Open	High	Low	Value	Volume
14.5¢	15.0¢	14.0¢	$95.42K	662.9K

Buyers (Bids)

No.	Vol.	Price($)
6	168013	14.0¢

Sellers (Offers)

Price($)	Vol.	No.
15.0¢	1440985	13

View Market Depth

No.	Vol.	Price($)
4	81713	0.140
9	467831	0.135
5	536915	0.130
13	965601	0.125
23	1268953	0.120

Price($)	Vol.	No.
0.150	1420985	12
0.155	725000	4
0.160	414400	4
0.165	200000	1
0.170	411812	5

Last trade - 16.10pm 28/06/2024 (20 minute delay)

ALA (ASX) Chart

Has Suda turned the corner!, page-33

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Has Suda turned the corner!, page-33

Top Stories

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News